Carmignac Gestion’s Exact Sciences EXAS Stock Holding History

Carmignac Gestion’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-81,354	Closed	-$8.26M	–	126
2025 Q4	$8.26M	Buy	+81,354	New	+$6.53M	0.11%	61
2020 Q2	–	Sell	-939,936	Closed	-$54.5M	–	132
2020 Q1	$54.5M	Buy	939,936 +65,921	+8%	+$5.35M	0.93%	37
2019 Q4	$80.8M	Buy	+874,015	New	+$76.8M	1.08%	34

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Carmignac Gestion's EXAS Position: Q1 2026 in Review

Carmignac Gestion sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 81,354 shares — an estimated $8.26M sold.

Carmignac Gestion first reported a position in EXAS in Q4 2019 and held it in 3 quarters. The position peaked at $80.8M in Q4 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Carmignac Gestion reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Carmignac Gestion sold 81,354 Exact Sciences shares in Q1 2026, an estimated $8.26M.
Carmignac Gestion first reported a position in Exact Sciences in Q4 2019 and held it in 3 quarters.
Carmignac Gestion's Exact Sciences position peaked at $80.8M in Q4 2019.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Carmignac Gestion's 13F filing for Q1 2026, filed 15 Jun 2026.